Change in healthcare resource use and associated costs of patients with metastatic lung cancer between 2013 and 2019: An observational study from the French national claims database

被引：0
|
作者：
Chouaid, C. [1 ]
Marchal, C. [2 ]
Apert, M. [3 ]
Bensimon, L. [3 ]
Guimard, V. [4 ]
Nee, M. [5 ]
Belhassen, M. [2 ]
de Pouvourville, G. [6 ]
Blay, J-Y. [7 ]
机构：
[1] CHI Ctr Hosp Intercommunal Creteil, Dept Pneumol, Creteil, France
[2] PELyon, Hlth Econ & Outcomes Res, Lyon, France
[3] MSD France, Hlth Econ & Outcomes Res, Puteaux La Defense, France
[4] MSD France, Med Affairs, Puteaux La Defense, France
[5] PELyon, Biostat, Lyon, France
[6] ESSEC Business Sch, Econ, Cergy, France
[7] Ctr Leon Berard, Dept Med, Lyon, France
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2448
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1417P
引用
收藏
页数：1
相关论文
共 49 条
  • [31] HEALTHCARE RESOURCE UTILIZATION (HCRU) AND COSTS AMONG PREVIOUSLY-TREATED PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER (MNSCLC): A RETROSPECTIVE ANALYSIS OF SEER-MEDICARE LINKED CLAIMS
    Rai, P.
    Paratane, D.
    Turkistani, F.
    Min, J.
    Rajagopalan, K.
    Hu, X.
    VALUE IN HEALTH, 2024, 27 (06) : S386 - S386
  • [32] Generic antiretroviral use in HIV-infected patients: a cohort study from the French national healthcare insurance database in midi-pyrenees region
    Rwagitinywa, J.
    Sommet, A.
    Bourrel, R.
    Montastruc, J. L.
    Lapeyre-Mestre, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2016, 30 : 55 - 55
  • [33] ESTIMATED COSTS OF HER2-POSITIVE METASTATIC BREAST CANCER FOR PATIENTS INITIATING AN ORAL ANTICANCER TREATMENT: RESULTS FROM A FRENCH PROSPECTIVE OBSERVATIONAL STUDY
    Woronoff-Lemsi, M. C.
    Chaix-Couturier, C.
    Durand-Zaleski, I
    Espic, M.
    Lortholary, A.
    Merrouche, Y.
    Flinois, A.
    Chabernaud, H.
    Benjamin, L.
    VALUE IN HEALTH, 2013, 16 (07) : A405 - A405
  • [34] TREATMENT PATTERNS, SURVIVAL, AND HEALTHCARE RESOURCE USE OF PATIENTS WITH ADVANCED MERKEL CELL CARCINOMA IN ENGLAND FROM 2013-2018: RESULTS OF A LONGITUDINAL OBSERVATIONAL COHORT STUDY
    Palencia, R.
    Knott, C.
    Mahmoudpour, S. H.
    Kolitsopoulos, F.
    Amin, A.
    Verpillat, P.
    VALUE IN HEALTH, 2022, 25 (01) : S114 - S114
  • [35] Resource Use and Costs Associated to the Initial Phase of Treatment for Patients with Colorectal Cancer Receiving Post-Surgery Chemotherapy: A Cost Analysis from a Healthcare Perspective
    Nejati, Mina
    Razavi, Moaven
    Harirchi, Iraj
    Zanganeh, Marzieh
    Salari, Gholanireza
    Tabatabaee, Seyed Mosa
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2021, 50 (09) : 1887 - 1896
  • [36] COMPARING HEALTH CARE RESOURCE USE, COSTS AND ADVERSE EVENTS AMONG LUNG CANCER PATIENTS TREATED WITH STANDARD CHEMOTHERAPY WITH OR WITHOUT AN ANGIOGENESIS INHIBITOR: A RETROSPECTIVE DATABASE STUDY
    Lang, K.
    Huang, H.
    Foley, D.
    Finnern, H. W.
    Menzin, J.
    VALUE IN HEALTH, 2012, 15 (04) : A213 - A213
  • [37] HEALTHCARE RESOURCE UTILIZATION AND ASSOCIATED COSTS IN COPD PATIENTS AT HIGH RISK OF EXACERBATION DESPITE TREATMENT WITH DUAL OR TRIPLE INHALED THERAPY: RESULTS FROM THE SIRIUS OBSERVATIONAL STUDY IN THE US
    Nordon, C.
    Carstens, D.
    Fageras, M.
    Mullerova, H.
    Anderson, A. J.
    Veeranki, P.
    Branscombe, N.
    Barnes, T.
    McCormack, M.
    VALUE IN HEALTH, 2024, 27 (06) : S359 - S359
  • [38] EFFECTIVENESS AND MEDICAL COSTS OF ABIRATERONE ACETATE VERSUS DOCETAXEL IN FIRST-LINE TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER FROM THE FRENCH NATIONWIDE CLAIMS DATABASE (SNDS): CAMERRA STUDY
    Thurin, N.
    Rouyer, M.
    Gross-Goupil, M.
    Haaser, T.
    Rebillard, X.
    Soulie, M.
    Messaoudi, F.
    Capone, C.
    Bignon, E.
    Lamarque, S.
    Jove, J.
    Droz-Perroteau, C.
    Moore, N.
    de Pouvourville, G.
    Blin, P.
    VALUE IN HEALTH, 2020, 23 : S424 - S424
  • [39] REAL-WORLD HEALTHCARE RESOURCE USE, COSTS, AND TREATMENT PATTERNS IN ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER PATIENTS WITH DIFFERENT EPIDERMAL GROWTH FACTOR RECEPTOR MUTATION TYPES
    Vadagam, P.
    Chen, J.
    Lee, I
    Tian, D.
    Waters, D. D.
    Near, A.
    Lyle, D.
    Vanderpoel, J.
    VALUE IN HEALTH, 2023, 26 (06) : S86 - S86
  • [40] HOSPITAL COSTS IN RESECTED PATIENTS WITH EARLYSTAGE NON-SMALL CELL LUNG CANCER (NSCLC): A FRENCH REAL-WORLD RETROSPECTIVE STUDY BASED ON THE NATIONAL HOSPITALIZATION DATABASE (PMSI)
    Renaud, S.
    Brouquet, A.
    Casabianca, P.
    Diez-Andreu, P.
    Chartier, M.
    Reynaud, D.
    Gaudin, A. F.
    Bugnard, F.
    Benard, S.
    Cotte, F. E.
    Chouaid, C.
    VALUE IN HEALTH, 2023, 26 (12) : S151 - S151
12345